Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR2500110940Phase 4Not yet recruiting
Phase 4, randomised, open-label trial in Mycoplasmal pneumonia comparing Doxycycline group with Azithromycin group (2 arms). Primary endpoint: Defervescence time. Planned start Oct 2025; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR2500110940.